Colorectal carcinoma in Western Libya: a Retrospective Study on Libyan Patients treated at Subrata National Cancer Institute (SNCI) in 2024
DOI:
https://doi.org/10.54361/LJMR.19.2.06Keywords:
Colorectal cancer, age, sex, family history of CRC, family history colorectal polyps, regional diAbstract
Background: Cancer is an important health concern in Libya, especially in the setting of an aging population and limited healthcare facilities. Colorectal cancer (CRC) is one of them. The prevalence of CRC in the world has demonstrated a notable upward trend in recent years, ranking as the second most common cancer among men and the third among women. This research aims to study CRC in the western region of Libya in terms of some non-modifiable risk factors such as age, gender, regional distribution, and genetic predisposition. Method and Methods: A retrospective descriptive study was conducted involving 202 individuals diagnosed with colorectal cancer at the Subrata National Cancer Institute (SNCI) in 2024, aiming to represent colorectal cancer among Libyan patients. Results: Overall, cancer was more prevalent among males than females; it affected 113 (55.9%) males and 89 (44.1%) females. 149 (73.8%) of all recorded cases were found in coastal areas, the area documented the highest percentage of all cases found in the western region of Libya. About 43.1% of patients were >60 years old, followed by 33.7% within the age group of 51-60 years old. In this study, patients presented with anemia, with mean hemoglobin levels appearing lower in females compared to males. 24.2% of patients have a positive family history of CRC, and only 5.4% have a positive family history of colorectal polyps.. Conclusion: The current Libyan CRC cohort shows that the average age at diagnosis was more than 60 years, with a male gender predominance. All patients presented with low hemoglobin levels. CRC occurred more frequently in coastal areas than in mountainous areas in Libya's western region.
Downloads
References
1- Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021 Jul;14(10):101174. doi:10.1016/j.tranon.2021.101174. PMID: 34243011; PMCID: PMC8273208.
2- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi:10.3322/caac.21660. PMID: 33538338.
3- Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
4- Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8. PMID: 36604116.
5- Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019 Mar;4(3):e137-e147. doi: 10.1016/S2468-2667(18)30267-6. Epub 2019 Feb 4. PMID: 30733056.
6- Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023 May-Jun;73(3):233-254. doi: 10.3322/caac.21772. Epub 2023 Mar 1. PMID: 36856579.
7- Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5. PMID: 32133645.
8- Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019 Oct 19;394(10207):1467-1480. doi: 10.1016/S0140-6736(19)32319-0. PMID: 31631858.
9- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
10- Virginie MLIL, Zhao Q, Liu L. African colorectal cancer burden in 2022 and projections to 2050. Ecancermedicalscience. 2024 Sep 26;18:1780. doi: 10.3332/ecancer.2024.1780. PMID: 39430071; PMCID: PMC11489094.
11- Arhin N, Ssentongo P, Taylor M, Olecki EJ, Pameijer C, Shen C, Oh J, Eng C. Age-standardised incidence rate and epidemiology of colorectal cancer in Africa: a systematic review and meta-analysis. BMJ Open. 2022 Jan 17;12(1):e052376. doi: 10.1136/bmjopen-2021-052376. PMID: 35039287; PMCID: PMC8765019.
12- Herrag SEE, Moulessehoul S, Mehadji DE, Yekrou D, Khaled MB. Epidemiological insights into colorectal cancer in northwestern Algeria. Ecancermedicalscience. 2024 Mar 21;18:1684. doi: 10.3332/ecancer.2024.1684. PMID: 38566765; PMCID: PMC10984843.
13- Khiari H, Ben Ayoub HW, Ben Khadhra H, Hsairi M. Colorectal Cancer Incidence Trend and Projections in Tunisia (1994 - 2024). Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2733-2739. doi: 10.22034/APJCP.2017.18.10.2733. PMID: 29072401; PMCID: PMC5747397.
14- Abuderman A, Alhadi A, Alhadi M, et al. Cancer incidence in eastern Libya: First results from Benghazi Medical Center. Pan Afr Med J. 2014 May 28;18:234.
15- Bodalal Z, Azzuz R, Bendardaf R. Cancers in Eastern Libya: first results from Benghazi Medical Center. World J Gastroenterol. 2014 May 28;20(20):6293-301. doi: 10.3748/wjg.v20.i20.6293. PMID: 24876750; PMCID: PMC4033467.
16- Gusbi E, Eltaib FI, Abrahem AF, Benbubaker WM, Alhudiri IM, Al-dabea SA, et al. Cancer incidence in southern Libya: updated report from 2016 to 2018. Libyan J Med Sci. 2021;5(1):11-16. doi:10.4103/LJMS.LJMS_74_20.
17- La Vecchia S, Sebastián C. Metabolic pathways regulating colorectal cancer initiation and progression. Semin Cell Dev Biol. 2020 Feb;98:63-70. doi: 10.1016/j.semcdb.2019.05.018. Epub 2019 May 28. PMID: 31129171.
18- Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010 Jun;138(6):2044-58. doi: 10.1053/j.gastro.2010.01.054. PMID: 20420945; PMCID: PMC3057468.
19- Valle L, de Voer RM, Goldberg Y, Sjursen W, Försti A, Ruiz-Ponte C, Caldés T, Garré P, Olsen MF, Nordling M, Castellvi-Bel S, Hemminki K. Update on genetic predisposition to colorectal cancer and polyposis. Mol Aspects Med. 2019 Oct;69:10-26. doi: 10.1016/j.mam.2019.03.001. Epub 2019 Mar 18. PMID: 30862463.
20- Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I, Lipton L, Young GP, Young JP, Lodge CJ, Southey MC, Newcomb PA, Le Marchand L, Haile RW, Lindor NM, Gallinger S, Hopper JL, Jenkins MA. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011 Jul;60(7):950-7. doi: 10.1136/gut.2010.228056. Epub 2010 Dec 30. PMID: 21193451; PMCID: PMC3848416.
21- Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017 Apr 1;35(10):1086-1095. doi: 10.1200/JCO.2016.71.0012. Epub 2017 Jan 30. PMID: 28135145; PMCID: PMC5455355.
22- Montazeri Z, Li X, Nyiraneza C, Ma X, Timofeeva M, Svinti V, Meng X, He Y, Bo Y, Morgan S, Castellví-Bel S, Ruiz-Ponte C, Fernández-Rozadilla C, Carracedo Á, Castells A, Bishop T, Buchanan D, Jenkins MA, Keku TO, Lindblom A, van Duijnhoven FJB, Wu A, Farrington SM, Dunlop MG, Campbell H, Theodoratou E, Zheng W, Little J. Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer. Gut. 2020 Aug;69(8):1460-1471. doi: 10.1136/gutjnl-2019-319313. Epub 2019 Dec 9. PMID: 31818908; PMCID: PMC7398467.
23- Zhang B, Jia WH, Matsuda K, Kweon SS, Matsuo K, Xiang YB, Shin A, Jee SH, Kim DH, Cai Q, Long J, Shi J, Wen W, Yang G, Zhang Y, Li C, Li B, Guo Y, Ren Z, Ji BT, Pan ZZ, Takahashi A, Shin MH, Matsuda F, Gao YT, Oh JH, Kim S, Ahn YO; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO); Chan AT, Chang-Claude J, Slattery ML; Colorectal Transdisciplinary (CORECT) Study; Gruber SB, Schumacher FR, Stenzel SL; Colon Cancer Family Registry (CCFR); Casey G, Kim HR, Jeong JY, Park JW, Li HL, Hosono S, Cho SH, Kubo M, Shu XO, Zeng YX, Zheng W. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat Genet. 2014 Jun;46(6):533-42. doi: 10.1038/ng.2985. Epub 2014 May 18. PMID: 24836286; PMCID: PMC4068797.
24- Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology. 2010 Mar;138(3):877-85. doi: 10.1053/j.gastro.2009.11.044. Epub 2009 Dec 21. PMID: 19932107; PMCID: PMC2831153.
25- Taylor DP, Stoddard GJ, Burt RW, Williams MS, Mitchell JA, Haug PJ, Cannon-Albright LA. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med. 2011 May;13(5):385-91. doi: 10.1097/GIM.0b013e3182064384. PMID: 21270638.
26- Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med. 2012 May 15;156(10):703-9. doi: 10.7326/0003-4819-156-10-201205150-00006. PMID: 22586009.
27- Song M, Emilsson L, Roelstraete B, Ludvigsson JF. Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden. BMJ. 2021 May 4;373:n877. doi: 10.1136/bmj.n877. PMID: 33947661; PMCID: PMC8083372.
28- Walker J, Quirke P. Biology and genetics of colorectal cancer. Eur J Cancer. 2001 Oct;37 Suppl 7:S163-72. doi: 10.1016/s0959-8049(01)80018-6. PMID: 11887987.
29- Christopoulou A. Chemotherapy in metastatic colorectal cancer. Tech Coloproctol. 2004 Nov;8 Suppl 1:s43-6. doi: 10.1007/s10151-004-0108-7. PMID: 15655639.
30- Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A, Corbex M, El-Saghir N, Habib OS, Maziak W, Mokhtar HC, Seif-Eldrin IA, Sobue T. Cancer epidemiology and control in the arab world - past, present and future. Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):3-16. PMID: 19469617.
31- Elzouki AN, Alkhomsi S. Pattern of gastrointestinal tract cancer in the Eastern part of Libya. Garyounis Med J. 2005;22:27-31
32- Schneider NI, Langner C. Prognostic stratification of colorectal cancer patients: current perspectives. Cancer Manag Res. 2014 Jul 2;6:291-300. doi: 10.2147/CMAR.S38827. PMID: 25061338; PMCID: PMC4085313.
33- Pirzada MT, Ahmed MJ, Muzzafar A, Nasir IUI, Shah MF, Khattak S, Syed AA. Rectal Carcinoma: Demographics and Clinicopathological Features from Pakistani Population Perspective. Cureus. 2017 Jun 20;9(6):e1375. doi: 10.7759/cureus.1375. PMID: 28744422; PMCID: PMC5519317.
34- Merika E, Saif MW, Katz A, Syrigos K, Morse M. Review. Colon cancer vaccines: an update. In Vivo. 2010 Sep-Oct;24(5):607-28. Erratum in: In Vivo. 2010 Nov-Dec;24(6):905. Syrigos, C [corrected to Syrigos, K]. PMID: 20952724.
35- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516. PMID: 21351269.
36- Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C, Faivre J. Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum. 2001 Mar;44(3):380-7. doi: 10.1007/BF02234737. PMID: 11289284.
37- Isbister WH. Malignant neoplasia of the colon, rectum and anus at the King Faisal Specialist Hospital and Research Centre. Ann Saudi Med. 1992 Sep;12(5):429-33. doi: 10.5144/0256-4947.1992.429. PMID: 17587016.
38- Elamyal R, Kamoka H, Hashmi H. Clinico-demographic profile of colorectal cancer patients in National Cancer Institute of Sabratha–Libya. J Med Sci Clin Res. 2017;5:31123-6.
39- Zhang C, Yin S, Tan Y, Huang J, Wang P, Hou W, Zhang Z, Xu H. Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer: A Systematic Review and Meta-Analysis. Am J Clin Oncol. 2020 Apr;43(4):279-287. doi: 10.1097/COC.0000000000000663. PMID: 31934881.
40- Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. Oxford: John Wiley & Sons; 2017.
41- Bakeer A, Zubia N, Belhaj E. A clinical and demographic profile of colorectal cancer: one year experience of National Cancer Institute, Misrata, Libya. Libyan Int J Oncol. 2022;1(2):59-63.
42- Gado A, Ebeid B, Abdelmohsen A, Axon A. Colorectal cancer in Egypt is commoner in young people: Is this cause for alarm? Alexandria J Med. 2014;50(3):197-201.
43- Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732. doi: 10.1038/s41575-019-0189-8. Epub 2019 Aug 27. PMID: 31455888.
44- Edgren G, Liang L, Adami HO, Chang ET. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012 Mar;27(3):187-96. doi: 10.1007/s10654-011-9647-5. Epub 2012 Jan 3. PMID: 22212865.
45- Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1629-37. doi: 10.1158/1055-9965.EPI-11-0246. Epub 2011 Jul 12. PMID: 21750167; PMCID: PMC3153584.
46- Jin EH, Han K, Shin CM, Lee DH, Kang SJ, Lim JH, Choi YJ. Sex and Tumor-Site Differences in the Association of Alcohol Intake With the Risk of Early-Onset Colorectal Cancer. J Clin Oncol. 2023 Aug 1;41(22):3816-3825. doi: 10.1200/JCO.22.01895. Epub 2023 Jun 14. PMID: 37315287; PMCID: PMC10419447.
47- Lee S, Woo H, Lee J, Oh JH, Kim J, Shin A. Cigarette smoking, alcohol consumption, and risk of colorectal cancer in South Korea: A case-control study. Alcohol. 2019 May;76:15-21. doi: 10.1016/j.alcohol.2018.06.004. Epub 2018 Jun 26. PMID: 30529018.
48- Kim I, Lee HH, Ko YJ, Chang HE, Cheung DY, Lee BI, Cho YS, Kim JI, Choi MG. Factors associated with the risk of colorectal neoplasia in young adults under age 40. Korean J Intern Med. 2022 Sep;37(5):969-978. doi: 10.3904/kjim.2021.506. Epub 2022 Jul 25. PMID: 35872626; PMCID: PMC9449198.
49- Ortega LS, Bradbury KE, Cross AJ, Morris JS, Gunter MJ, Murphy N. A Prospective Investigation of Body Size, Body Fat Composition and Colorectal Cancer Risk in the UK Biobank. Sci Rep. 2017 Dec 19;7(1):17807. doi: 10.1038/s41598-017-17997-5. PMID: 29259258; PMCID: PMC5736687.
50- Rodríguez-Santiago Y, Terrazas-Valdés LI, Nava-Castro KE, Del Río-Araiza VH, Garay-Canales CA, Morales-Montor J. Sexual dimorphism of colorectal cancer in humans and colorectal tumors in a murine model. Front Oncol. 2024 Aug 6;14:1398175. doi: 10.3389/fonc.2024.1398175. PMID: 39165688; PMCID: PMC11333323.
51- Song CH, Kim N, Nam RH, Choi SI, Yu JE, Nho H, Shin E, Lee HN, Surh YJ. Testosterone strongly enhances azoxymethane/dextran sulfate sodium-induced colorectal cancer development in C57BL/6 mice. Am J Cancer Res. 2021 Jun 15;11(6):3145-3162. PMID: 34249451; PMCID: PMC8263677.
52- Leiszter K, Galamb O, Kalmár A, Zsigrai S, Valcz G, Szigeti KA, Barták BK, Nagy ZB, Dank M, Liposits Z, Igaz P, Tulassay Z, Molnár B. Az ösztrogének lehetséges szerepe a vastagbéldaganatok kialakulásában [Potential role of estrogens in colorectal tumour development]. Orv Hetil. 2020 Apr;161(14):532-543. Hungarian. doi: 10.1556/650.2020.31674. PMID: 32223415.
53- Bhattacharya P, Leslie SW, McHugh TW. Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer). 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 28613748.
54- Menon G, Kasi A. Familial Adenomatous Polyposis. 2024 May 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30855821.
55- Mesher D, Dove-Edwin I, Sasieni P, Vasen H, Bernstein I, Royer-Pokora B, Holinski-Feder E, Lalloo F, Evans DG, Forsberg A, Lindblom A, Thomas H. A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer. Int J Cancer. 2014 Feb 15;134(4):939-47. doi: 10.1002/ijc.28397. Epub 2013 Aug 29. PMID: 23901040.
56- Armelao F, de Pretis G. Familial colorectal cancer: a review. World J Gastroenterol. 2014 Jul 28;20(28):9292-8. doi: 10.3748/wjg.v20.i28.9292. PMID: 25071323; PMCID: PMC4110560.
57- Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, Saslow D, Cokkinides V, Eyre H; ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin. 2001 Jan-Feb;51(1):38-75; quiz 77-80. doi: 10.3322/canjclin.51.1.38. Erratum in: CA Cancer J Clin 2001 May-Jun;51(3):150. PMID: 11577479.
58- Jung YS, Song H, Tran MTX, Park B, Moon CM. Association between A Family History of Colorectal Cancer and the Risk of Colorectal Cancer: A Nationwide Population-Based Study. J Pers Med. 2022 Sep 23;12(10):1566. doi: 10.3390/jpm12101566. PMID: 36294706; PMCID: PMC9605451.
59- Keivanlou MH, Amini-Salehi E, Joukar F, Letafatkar N, Habibi A, Norouzi N, Vakilpour A, Aleali MS, Rafat Z, Ashoobi MT, Mansour-Ghanaei F, Hassanipour S. Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: a systematic review and meta-analysis. Sci Rep. 2023 Oct 14;13(1):17457. doi: 10.1038/s41598-023-44487-8. PMID: 37838786; PMCID: PMC10576738.
60- Wong MC, Chan CH, Lin J, Huang JL, Huang J, Fang Y, et al. Lower relative contribution of positive family history to colorectal cancer risk with increasing age: a systematic review and meta-analysis of 9.28 million individuals. Am J Gastroenterol. 2018;113(12):1819-27.10.1038/s41395-018-0271-0.
61- Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021 Mar 1;116(3):458-479. doi: 10.14309/ajg.0000000000001122. PMID: 33657038.
62- Douaiher J, Ravipati A, Grams B, Chowdhury S, Alatise O, Are C. Colorectal cancer-global burden, trends, and geographical variations. J Surg Oncol. 2017 Apr;115(5):619-630. doi: 10.1002/jso.24578. Epub 2017 Feb 13. PMID: 28194798.
63- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
64- Dong W, Kim U, Rose J, Hoehn RS, Kucmanic M, Eom K, Li S, Berger NA, Koroukian SM. Geographic Variation and Risk Factor Association of Early Versus Late Onset Colorectal Cancer. Cancers (Basel). 2023 Feb 4;15(4):1006. doi: 10.3390/cancers15041006. PMID: 36831350; PMCID: PMC9954005.
65- Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, Wu K, Cao Y, Ng K, Ogino S. Rising incidence of early-onset colorectal cancer - a call to action. Nat Rev Clin Oncol. 2021 Apr;18(4):230-
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sumaya Taher Draa , Fadia T.M Oshkondale, Adel .M .Abdallaa, Mohamed Khalifa Al- Kawash, Mohamed Mohamed Altoumi, Kholoud Abd Al-Razzaq Kardmain, Khitam Mohamed Al-Shein (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
